Global Graft Versus Host Disease Treatment Supply, Demand and Key Producers, 2023-2029

Page: 121

Published Date: 05 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Graft Versus Host Disease Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Graft Versus Host Disease Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Graft Versus Host Disease Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Graft Versus Host Disease Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Graft Versus Host Disease Treatment total market, 2018-2029, (USD Million)
Global Graft Versus Host Disease Treatment total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Graft Versus Host Disease Treatment total market, key domestic companies and share, (USD Million)
Global Graft Versus Host Disease Treatment revenue by player and market share 2018-2023, (USD Million)
Global Graft Versus Host Disease Treatment total market by Type, CAGR, 2018-2029, (USD Million)
Global Graft Versus Host Disease Treatment total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Graft Versus Host Disease Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc., Acrofan, Astellas Pharma Inc., Bristol-Myers Squibb Company, ElsaLys Biotech SA, F. Hoffmann-La Roche AG, Johnson & Johnson, Mallinckrodft PLC and Merck & Co., Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Graft Versus Host Disease Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Graft Versus Host Disease Treatment Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Graft Versus Host Disease Treatment Market, Segmentation by Type
Etanercept
Monoclonal Antibodies
Thalidomide
Tyrosine Kinase Inhibitors
mTOR Inhibitors

Global Graft Versus Host Disease Treatment Market, Segmentation by Application
Acute GVHD
Chronic GVHD
Prophylaxis GVHD

Companies Profiled:
AbbVie Inc.
Acrofan
Astellas Pharma Inc.
Bristol-Myers Squibb Company
ElsaLys Biotech SA
F. Hoffmann-La Roche AG
Johnson & Johnson
Mallinckrodft PLC
Merck & Co., Inc.
Mesoblast Limited
Neovii Biotech GmbH
Novartis AG
Ocugen, Inc.
Pfizer Inc
Pluristem Therapeutics Inc.
Samedan Ltd
Sanofi SA
Soligenix, Inc.

Key Questions Answered
1. How big is the global Graft Versus Host Disease Treatment market?
2. What is the demand of the global Graft Versus Host Disease Treatment market?
3. What is the year over year growth of the global Graft Versus Host Disease Treatment market?
4. What is the total value of the global Graft Versus Host Disease Treatment market?
5. Who are the major players in the global Graft Versus Host Disease Treatment market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Graft Versus Host Disease Treatment Introduction
    1.2 World Graft Versus Host Disease Treatment Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Graft Versus Host Disease Treatment Total Market by Region (by Headquarter Location)
        1.3.1 World Graft Versus Host Disease Treatment Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Graft Versus Host Disease Treatment Market Size (2018-2029)
        1.3.3 China Graft Versus Host Disease Treatment Market Size (2018-2029)
        1.3.4 Europe Graft Versus Host Disease Treatment Market Size (2018-2029)
        1.3.5 Japan Graft Versus Host Disease Treatment Market Size (2018-2029)
        1.3.6 South Korea Graft Versus Host Disease Treatment Market Size (2018-2029)
        1.3.7 ASEAN Graft Versus Host Disease Treatment Market Size (2018-2029)
        1.3.8 India Graft Versus Host Disease Treatment Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Graft Versus Host Disease Treatment Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Graft Versus Host Disease Treatment Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Graft Versus Host Disease Treatment Consumption Value (2018-2029)
    2.2 World Graft Versus Host Disease Treatment Consumption Value by Region
        2.2.1 World Graft Versus Host Disease Treatment Consumption Value by Region (2018-2023)
        2.2.2 World Graft Versus Host Disease Treatment Consumption Value Forecast by Region (2024-2029)
    2.3 United States Graft Versus Host Disease Treatment Consumption Value (2018-2029)
    2.4 China Graft Versus Host Disease Treatment Consumption Value (2018-2029)
    2.5 Europe Graft Versus Host Disease Treatment Consumption Value (2018-2029)
    2.6 Japan Graft Versus Host Disease Treatment Consumption Value (2018-2029)
    2.7 South Korea Graft Versus Host Disease Treatment Consumption Value (2018-2029)
    2.8 ASEAN Graft Versus Host Disease Treatment Consumption Value (2018-2029)
    2.9 India Graft Versus Host Disease Treatment Consumption Value (2018-2029)

3 World Graft Versus Host Disease Treatment Companies Competitive Analysis
    3.1 World Graft Versus Host Disease Treatment Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Graft Versus Host Disease Treatment Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Graft Versus Host Disease Treatment in 2022
        3.2.3 Global Concentration Ratios (CR8) for Graft Versus Host Disease Treatment in 2022
    3.3 Graft Versus Host Disease Treatment Company Evaluation Quadrant
    3.4 Graft Versus Host Disease Treatment Market: Overall Company Footprint Analysis
        3.4.1 Graft Versus Host Disease Treatment Market: Region Footprint
        3.4.2 Graft Versus Host Disease Treatment Market: Company Product Type Footprint
        3.4.3 Graft Versus Host Disease Treatment Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Graft Versus Host Disease Treatment Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Graft Versus Host Disease Treatment Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Graft Versus Host Disease Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Graft Versus Host Disease Treatment Consumption Value Comparison
        4.2.1 United States VS China: Graft Versus Host Disease Treatment Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Graft Versus Host Disease Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Graft Versus Host Disease Treatment Companies and Market Share, 2018-2023
        4.3.1 United States Based Graft Versus Host Disease Treatment Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Graft Versus Host Disease Treatment Revenue, (2018-2023)
    4.4 China Based Companies Graft Versus Host Disease Treatment Revenue and Market Share, 2018-2023
        4.4.1 China Based Graft Versus Host Disease Treatment Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Graft Versus Host Disease Treatment Revenue, (2018-2023)
    4.5 Rest of World Based Graft Versus Host Disease Treatment Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Graft Versus Host Disease Treatment Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Graft Versus Host Disease Treatment Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Graft Versus Host Disease Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Etanercept
        5.2.2 Monoclonal Antibodies
        5.2.3 Thalidomide
        5.2.4 Tyrosine Kinase Inhibitors
        5.2.5 mTOR Inhibitors
    5.3 Market Segment by Type
        5.3.1 World Graft Versus Host Disease Treatment Market Size by Type (2018-2023)
        5.3.2 World Graft Versus Host Disease Treatment Market Size by Type (2024-2029)
        5.3.3 World Graft Versus Host Disease Treatment Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Graft Versus Host Disease Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Acute GVHD
        6.2.2 Chronic GVHD
        6.2.3 Prophylaxis GVHD
    6.3 Market Segment by Application
        6.3.1 World Graft Versus Host Disease Treatment Market Size by Application (2018-2023)
        6.3.2 World Graft Versus Host Disease Treatment Market Size by Application (2024-2029)
        6.3.3 World Graft Versus Host Disease Treatment Market Size by Application (2018-2029)

7 Company Profiles
    7.1 AbbVie Inc.
        7.1.1 AbbVie Inc. Details
        7.1.2 AbbVie Inc. Major Business
        7.1.3 AbbVie Inc. Graft Versus Host Disease Treatment Product and Services
        7.1.4 AbbVie Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 AbbVie Inc. Recent Developments/Updates
        7.1.6 AbbVie Inc. Competitive Strengths & Weaknesses
    7.2 Acrofan
        7.2.1 Acrofan Details
        7.2.2 Acrofan Major Business
        7.2.3 Acrofan Graft Versus Host Disease Treatment Product and Services
        7.2.4 Acrofan Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Acrofan Recent Developments/Updates
        7.2.6 Acrofan Competitive Strengths & Weaknesses
    7.3 Astellas Pharma Inc.
        7.3.1 Astellas Pharma Inc. Details
        7.3.2 Astellas Pharma Inc. Major Business
        7.3.3 Astellas Pharma Inc. Graft Versus Host Disease Treatment Product and Services
        7.3.4 Astellas Pharma Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Astellas Pharma Inc. Recent Developments/Updates
        7.3.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
    7.4 Bristol-Myers Squibb Company
        7.4.1 Bristol-Myers Squibb Company Details
        7.4.2 Bristol-Myers Squibb Company Major Business
        7.4.3 Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Product and Services
        7.4.4 Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Bristol-Myers Squibb Company Recent Developments/Updates
        7.4.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    7.5 ElsaLys Biotech SA
        7.5.1 ElsaLys Biotech SA Details
        7.5.2 ElsaLys Biotech SA Major Business
        7.5.3 ElsaLys Biotech SA Graft Versus Host Disease Treatment Product and Services
        7.5.4 ElsaLys Biotech SA Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 ElsaLys Biotech SA Recent Developments/Updates
        7.5.6 ElsaLys Biotech SA Competitive Strengths & Weaknesses
    7.6 F. Hoffmann-La Roche AG
        7.6.1 F. Hoffmann-La Roche AG Details
        7.6.2 F. Hoffmann-La Roche AG Major Business
        7.6.3 F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Product and Services
        7.6.4 F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 F. Hoffmann-La Roche AG Recent Developments/Updates
        7.6.6 F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
    7.7 Johnson & Johnson
        7.7.1 Johnson & Johnson Details
        7.7.2 Johnson & Johnson Major Business
        7.7.3 Johnson & Johnson Graft Versus Host Disease Treatment Product and Services
        7.7.4 Johnson & Johnson Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Johnson & Johnson Recent Developments/Updates
        7.7.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.8 Mallinckrodft PLC
        7.8.1 Mallinckrodft PLC Details
        7.8.2 Mallinckrodft PLC Major Business
        7.8.3 Mallinckrodft PLC Graft Versus Host Disease Treatment Product and Services
        7.8.4 Mallinckrodft PLC Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Mallinckrodft PLC Recent Developments/Updates
        7.8.6 Mallinckrodft PLC Competitive Strengths & Weaknesses
    7.9 Merck & Co., Inc.
        7.9.1 Merck & Co., Inc. Details
        7.9.2 Merck & Co., Inc. Major Business
        7.9.3 Merck & Co., Inc. Graft Versus Host Disease Treatment Product and Services
        7.9.4 Merck & Co., Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Merck & Co., Inc. Recent Developments/Updates
        7.9.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
    7.10 Mesoblast Limited
        7.10.1 Mesoblast Limited Details
        7.10.2 Mesoblast Limited Major Business
        7.10.3 Mesoblast Limited Graft Versus Host Disease Treatment Product and Services
        7.10.4 Mesoblast Limited Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Mesoblast Limited Recent Developments/Updates
        7.10.6 Mesoblast Limited Competitive Strengths & Weaknesses
    7.11 Neovii Biotech GmbH
        7.11.1 Neovii Biotech GmbH Details
        7.11.2 Neovii Biotech GmbH Major Business
        7.11.3 Neovii Biotech GmbH Graft Versus Host Disease Treatment Product and Services
        7.11.4 Neovii Biotech GmbH Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Neovii Biotech GmbH Recent Developments/Updates
        7.11.6 Neovii Biotech GmbH Competitive Strengths & Weaknesses
    7.12 Novartis AG
        7.12.1 Novartis AG Details
        7.12.2 Novartis AG Major Business
        7.12.3 Novartis AG Graft Versus Host Disease Treatment Product and Services
        7.12.4 Novartis AG Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Novartis AG Recent Developments/Updates
        7.12.6 Novartis AG Competitive Strengths & Weaknesses
    7.13 Ocugen, Inc.
        7.13.1 Ocugen, Inc. Details
        7.13.2 Ocugen, Inc. Major Business
        7.13.3 Ocugen, Inc. Graft Versus Host Disease Treatment Product and Services
        7.13.4 Ocugen, Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Ocugen, Inc. Recent Developments/Updates
        7.13.6 Ocugen, Inc. Competitive Strengths & Weaknesses
    7.14 Pfizer Inc
        7.14.1 Pfizer Inc Details
        7.14.2 Pfizer Inc Major Business
        7.14.3 Pfizer Inc Graft Versus Host Disease Treatment Product and Services
        7.14.4 Pfizer Inc Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Pfizer Inc Recent Developments/Updates
        7.14.6 Pfizer Inc Competitive Strengths & Weaknesses
    7.15 Pluristem Therapeutics Inc.
        7.15.1 Pluristem Therapeutics Inc. Details
        7.15.2 Pluristem Therapeutics Inc. Major Business
        7.15.3 Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Product and Services
        7.15.4 Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Pluristem Therapeutics Inc. Recent Developments/Updates
        7.15.6 Pluristem Therapeutics Inc. Competitive Strengths & Weaknesses
    7.16 Samedan Ltd
        7.16.1 Samedan Ltd Details
        7.16.2 Samedan Ltd Major Business
        7.16.3 Samedan Ltd Graft Versus Host Disease Treatment Product and Services
        7.16.4 Samedan Ltd Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Samedan Ltd Recent Developments/Updates
        7.16.6 Samedan Ltd Competitive Strengths & Weaknesses
    7.17 Sanofi SA
        7.17.1 Sanofi SA Details
        7.17.2 Sanofi SA Major Business
        7.17.3 Sanofi SA Graft Versus Host Disease Treatment Product and Services
        7.17.4 Sanofi SA Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Sanofi SA Recent Developments/Updates
        7.17.6 Sanofi SA Competitive Strengths & Weaknesses
    7.18 Soligenix, Inc.
        7.18.1 Soligenix, Inc. Details
        7.18.2 Soligenix, Inc. Major Business
        7.18.3 Soligenix, Inc. Graft Versus Host Disease Treatment Product and Services
        7.18.4 Soligenix, Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Soligenix, Inc. Recent Developments/Updates
        7.18.6 Soligenix, Inc. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Graft Versus Host Disease Treatment Industry Chain
    8.2 Graft Versus Host Disease Treatment Upstream Analysis
    8.3 Graft Versus Host Disease Treatment Midstream Analysis
    8.4 Graft Versus Host Disease Treatment Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Graft Versus Host Disease Treatment Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Graft Versus Host Disease Treatment Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Graft Versus Host Disease Treatment Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Graft Versus Host Disease Treatment Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Graft Versus Host Disease Treatment Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Graft Versus Host Disease Treatment Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Graft Versus Host Disease Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Graft Versus Host Disease Treatment Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Graft Versus Host Disease Treatment Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Graft Versus Host Disease Treatment Players in 2022
    Table 12. World Graft Versus Host Disease Treatment Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Graft Versus Host Disease Treatment Company Evaluation Quadrant
    Table 14. Head Office of Key Graft Versus Host Disease Treatment Player
    Table 15. Graft Versus Host Disease Treatment Market: Company Product Type Footprint
    Table 16. Graft Versus Host Disease Treatment Market: Company Product Application Footprint
    Table 17. Graft Versus Host Disease Treatment Mergers & Acquisitions Activity
    Table 18. United States VS China Graft Versus Host Disease Treatment Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Graft Versus Host Disease Treatment Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Graft Versus Host Disease Treatment Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Graft Versus Host Disease Treatment Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Graft Versus Host Disease Treatment Revenue Market Share (2018-2023)
    Table 23. China Based Graft Versus Host Disease Treatment Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Graft Versus Host Disease Treatment Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Graft Versus Host Disease Treatment Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Graft Versus Host Disease Treatment Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Graft Versus Host Disease Treatment Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Graft Versus Host Disease Treatment Revenue Market Share (2018-2023)
    Table 29. World Graft Versus Host Disease Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Graft Versus Host Disease Treatment Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Graft Versus Host Disease Treatment Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Graft Versus Host Disease Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Graft Versus Host Disease Treatment Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Graft Versus Host Disease Treatment Market Size by Application (2024-2029) & (USD Million)
    Table 35. AbbVie Inc. Basic Information, Area Served and Competitors
    Table 36. AbbVie Inc. Major Business
    Table 37. AbbVie Inc. Graft Versus Host Disease Treatment Product and Services
    Table 38. AbbVie Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. AbbVie Inc. Recent Developments/Updates
    Table 40. AbbVie Inc. Competitive Strengths & Weaknesses
    Table 41. Acrofan Basic Information, Area Served and Competitors
    Table 42. Acrofan Major Business
    Table 43. Acrofan Graft Versus Host Disease Treatment Product and Services
    Table 44. Acrofan Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Acrofan Recent Developments/Updates
    Table 46. Acrofan Competitive Strengths & Weaknesses
    Table 47. Astellas Pharma Inc. Basic Information, Area Served and Competitors
    Table 48. Astellas Pharma Inc. Major Business
    Table 49. Astellas Pharma Inc. Graft Versus Host Disease Treatment Product and Services
    Table 50. Astellas Pharma Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Astellas Pharma Inc. Recent Developments/Updates
    Table 52. Astellas Pharma Inc. Competitive Strengths & Weaknesses
    Table 53. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
    Table 54. Bristol-Myers Squibb Company Major Business
    Table 55. Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Product and Services
    Table 56. Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Bristol-Myers Squibb Company Recent Developments/Updates
    Table 58. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    Table 59. ElsaLys Biotech SA Basic Information, Area Served and Competitors
    Table 60. ElsaLys Biotech SA Major Business
    Table 61. ElsaLys Biotech SA Graft Versus Host Disease Treatment Product and Services
    Table 62. ElsaLys Biotech SA Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. ElsaLys Biotech SA Recent Developments/Updates
    Table 64. ElsaLys Biotech SA Competitive Strengths & Weaknesses
    Table 65. F. Hoffmann-La Roche AG Basic Information, Area Served and Competitors
    Table 66. F. Hoffmann-La Roche AG Major Business
    Table 67. F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Product and Services
    Table 68. F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. F. Hoffmann-La Roche AG Recent Developments/Updates
    Table 70. F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
    Table 71. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 72. Johnson & Johnson Major Business
    Table 73. Johnson & Johnson Graft Versus Host Disease Treatment Product and Services
    Table 74. Johnson & Johnson Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Johnson & Johnson Recent Developments/Updates
    Table 76. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 77. Mallinckrodft PLC Basic Information, Area Served and Competitors
    Table 78. Mallinckrodft PLC Major Business
    Table 79. Mallinckrodft PLC Graft Versus Host Disease Treatment Product and Services
    Table 80. Mallinckrodft PLC Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Mallinckrodft PLC Recent Developments/Updates
    Table 82. Mallinckrodft PLC Competitive Strengths & Weaknesses
    Table 83. Merck & Co., Inc. Basic Information, Area Served and Competitors
    Table 84. Merck & Co., Inc. Major Business
    Table 85. Merck & Co., Inc. Graft Versus Host Disease Treatment Product and Services
    Table 86. Merck & Co., Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Merck & Co., Inc. Recent Developments/Updates
    Table 88. Merck & Co., Inc. Competitive Strengths & Weaknesses
    Table 89. Mesoblast Limited Basic Information, Area Served and Competitors
    Table 90. Mesoblast Limited Major Business
    Table 91. Mesoblast Limited Graft Versus Host Disease Treatment Product and Services
    Table 92. Mesoblast Limited Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Mesoblast Limited Recent Developments/Updates
    Table 94. Mesoblast Limited Competitive Strengths & Weaknesses
    Table 95. Neovii Biotech GmbH Basic Information, Area Served and Competitors
    Table 96. Neovii Biotech GmbH Major Business
    Table 97. Neovii Biotech GmbH Graft Versus Host Disease Treatment Product and Services
    Table 98. Neovii Biotech GmbH Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Neovii Biotech GmbH Recent Developments/Updates
    Table 100. Neovii Biotech GmbH Competitive Strengths & Weaknesses
    Table 101. Novartis AG Basic Information, Area Served and Competitors
    Table 102. Novartis AG Major Business
    Table 103. Novartis AG Graft Versus Host Disease Treatment Product and Services
    Table 104. Novartis AG Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Novartis AG Recent Developments/Updates
    Table 106. Novartis AG Competitive Strengths & Weaknesses
    Table 107. Ocugen, Inc. Basic Information, Area Served and Competitors
    Table 108. Ocugen, Inc. Major Business
    Table 109. Ocugen, Inc. Graft Versus Host Disease Treatment Product and Services
    Table 110. Ocugen, Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Ocugen, Inc. Recent Developments/Updates
    Table 112. Ocugen, Inc. Competitive Strengths & Weaknesses
    Table 113. Pfizer Inc Basic Information, Area Served and Competitors
    Table 114. Pfizer Inc Major Business
    Table 115. Pfizer Inc Graft Versus Host Disease Treatment Product and Services
    Table 116. Pfizer Inc Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Pfizer Inc Recent Developments/Updates
    Table 118. Pfizer Inc Competitive Strengths & Weaknesses
    Table 119. Pluristem Therapeutics Inc. Basic Information, Area Served and Competitors
    Table 120. Pluristem Therapeutics Inc. Major Business
    Table 121. Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Product and Services
    Table 122. Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Pluristem Therapeutics Inc. Recent Developments/Updates
    Table 124. Pluristem Therapeutics Inc. Competitive Strengths & Weaknesses
    Table 125. Samedan Ltd Basic Information, Area Served and Competitors
    Table 126. Samedan Ltd Major Business
    Table 127. Samedan Ltd Graft Versus Host Disease Treatment Product and Services
    Table 128. Samedan Ltd Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. Samedan Ltd Recent Developments/Updates
    Table 130. Samedan Ltd Competitive Strengths & Weaknesses
    Table 131. Sanofi SA Basic Information, Area Served and Competitors
    Table 132. Sanofi SA Major Business
    Table 133. Sanofi SA Graft Versus Host Disease Treatment Product and Services
    Table 134. Sanofi SA Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Sanofi SA Recent Developments/Updates
    Table 136. Soligenix, Inc. Basic Information, Area Served and Competitors
    Table 137. Soligenix, Inc. Major Business
    Table 138. Soligenix, Inc. Graft Versus Host Disease Treatment Product and Services
    Table 139. Soligenix, Inc. Graft Versus Host Disease Treatment Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 140. Global Key Players of Graft Versus Host Disease Treatment Upstream (Raw Materials)
    Table 141. Graft Versus Host Disease Treatment Typical Customers
List of Figure
    Figure 1. Graft Versus Host Disease Treatment Picture
    Figure 2. World Graft Versus Host Disease Treatment Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Graft Versus Host Disease Treatment Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Graft Versus Host Disease Treatment Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Graft Versus Host Disease Treatment Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Graft Versus Host Disease Treatment Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Graft Versus Host Disease Treatment Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Graft Versus Host Disease Treatment Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Graft Versus Host Disease Treatment Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Graft Versus Host Disease Treatment Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Graft Versus Host Disease Treatment Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Graft Versus Host Disease Treatment Revenue (2018-2029) & (USD Million)
    Figure 13. Graft Versus Host Disease Treatment Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Graft Versus Host Disease Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Graft Versus Host Disease Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Graft Versus Host Disease Treatment by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Graft Versus Host Disease Treatment Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Graft Versus Host Disease Treatment Markets in 2022
    Figure 27. United States VS China: Graft Versus Host Disease Treatment Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Graft Versus Host Disease Treatment Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Graft Versus Host Disease Treatment Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Graft Versus Host Disease Treatment Market Size Market Share by Type in 2022
    Figure 31. Etanercept
    Figure 32. Monoclonal Antibodies
    Figure 33. Thalidomide
    Figure 34. Tyrosine Kinase Inhibitors
    Figure 35. mTOR Inhibitors
    Figure 36. World Graft Versus Host Disease Treatment Market Size Market Share by Type (2018-2029)
    Figure 37. World Graft Versus Host Disease Treatment Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Graft Versus Host Disease Treatment Market Size Market Share by Application in 2022
    Figure 39. Acute GVHD
    Figure 40. Chronic GVHD
    Figure 41. Prophylaxis GVHD
    Figure 42. Graft Versus Host Disease Treatment Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Graft Versus Host Disease Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Graft Versus Host Disease Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Medical Care

According to our (Global Info Research) latest study, the global Graft Versus Host Disease Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Graft Versus Host Disease Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Graft Versus Host Disease Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 23 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Graft Versus Host Disease Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Graft Versus Host Disease Treatment

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>